UroToday.com· @urotoday · X·· 1 天前评分45
正文 · 机器翻译
ctDNA 肿瘤分数作为 #TALAPRO3 中的预后生物标志物：Talazoparib + Enzalutamide 用于 HRR 突变的 #mCSPC。由 @AzadOncology @PeterMacCC 报告。#ESMO26 由 @zklaassen_md 撰写报道 > https://bit.ly/4zTljYw #ProstateCancer #PrecisionOncology @myESMO
257 浏览 · 3 赞 · 3 转发 · 0 回复
会议摘要
Utility of ctDNA tumor fraction (TF) as a prognostic biomarker in TALAPRO-3: phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA in patients (pts) with homologous recombination repair (HRR) gene–mutated metasta
https://esmocongress.esmo.org来源：UroToday.com · x.com